General Investing >> Money Manager Interviews >> May 5, 2003
Dr. Michael Dauchot, CFA, is a Portfolio Manager, a Senior Research Analyst and a Director with Allianz Global Investors, which he joined in 1999. He is a member of the health care team, focusing on medical technology, life science tools and diagnostics. Dr. Dauchot has 19 years of investment-industry experience. He previously worked at Pequot Capital Management and Robertson Stephens. Dr. Dauchot has a degree in chemistry from Case Western Reserve University, an MBA from the Kellogg School of Management at Northwestern University and an M.D. from the University of Cincinnati College of Medicine. Profile
DR. ERIC SHEN joined RCM Capital Management in 2001 as an Analyst in the
healthcare group, covering biotechnology. Prior to joining RCM, Dr. Shen
was a Biotechnology Analyst at Robertson Stephens, where he covered
product-focused biotechnology companies. Dr. Shen graduated from Yale
University magna cum laude with a BA in Biology and received an MD from
New York University. He trained in internal medicine and radiology at
Massachusetts General Hospital and Stanford University Hospital Profile
in 2002, and what is the outlook going forward?
Dr. Dauchot: Health care has actually done pretty well in the
past six months.
